In another study conducted by Erel-Akbaba et al., solid lipid NPs loaded with siRNA against human EGFR were found to exhibit dose-dependent EGFR knockdown when tested in human U87 glioma cells [126]. The gene discussed is EGFR; the disease is central nervous system cancer.